FI893460A - ANVAENDNING AV SUBSTITUERADE 3,4-DIHYDRO -2H-BENSOPYRANER SOM LAEKEMEDEL MOT FUNKTIONSSTOERNINGAR VILKA TILLTAEPPER LUNGORNA, OCH / ELLER STOERNINGAR I DE AVLEDANDE URINROEREN. - Google Patents

ANVAENDNING AV SUBSTITUERADE 3,4-DIHYDRO -2H-BENSOPYRANER SOM LAEKEMEDEL MOT FUNKTIONSSTOERNINGAR VILKA TILLTAEPPER LUNGORNA, OCH / ELLER STOERNINGAR I DE AVLEDANDE URINROEREN. Download PDF

Info

Publication number
FI893460A
FI893460A FI893460A FI893460A FI893460A FI 893460 A FI893460 A FI 893460A FI 893460 A FI893460 A FI 893460A FI 893460 A FI893460 A FI 893460A FI 893460 A FI893460 A FI 893460A
Authority
FI
Finland
Prior art keywords
dihydro
alkyl
urinroeren
tilltaepper
stoerningar
Prior art date
Application number
FI893460A
Other languages
Finnish (fi)
Other versions
FI893460A0 (en
Inventor
Heinrich Christian Englert
Erik Klaus
Dieter Mania
Bernward Schoelkens
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI893460A0 publication Critical patent/FI893460A0/en
Publication of FI893460A publication Critical patent/FI893460A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyrane Compounds (AREA)

Abstract

The use of 3,4-dihydro-2H-benzo[b]pyrans of the formula I <IMAGE> in which R<1> is H, OH, (C1-C2)-alkoxy, (C1-C2)-alkyl or NR<4>R<5>, where R<4> and R<5> are identical or different and are H, (C1-C2)-alkyl or (C1-C3)-alkylcarbonyl, R<2> and R<3> are identical or different and are alkyl with 1-4 C atoms, Ar is an aromatic or heteroaromatic system which is unsubstituted or substituted by 1 to 3 identical or different radicals (C1-C2)-alkyl, (C1-C2)-alkoxy, halogen, trifluoromethyl, CN, NO2, CO-(C1-C2)-alkyl or SOm-(C1-C2)-alkyl with m = 1 or 2, n is 1 or 2, X is a chain (CH2)r which can be interrupted by a heteroatom O, S or NR<6> where R<6> is H or (C1-C4)-alkyl and r is the numbers 2, 3, 4 or 5, for the production of a medicament for urinary tract disorders.
FI893460A 1988-07-19 1989-07-17 ANVAENDNING AV SUBSTITUERADE 3,4-DIHYDRO -2H-BENSOPYRANER SOM LAEKEMEDEL MOT FUNKTIONSSTOERNINGAR VILKA TILLTAEPPER LUNGORNA, OCH / ELLER STOERNINGAR I DE AVLEDANDE URINROEREN. FI893460A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3824446A DE3824446A1 (en) 1988-07-19 1988-07-19 USE OF SUBSTITUTED 3,4-DIHYDRO-2H-BENZOPYRANE AS A MEDICINE AGAINST OBSTRUCTIVE FUNCTIONAL DISORDERS OF THE LUNG AND / OR DISORDERS OF THE LEADING URINE PATHS

Publications (2)

Publication Number Publication Date
FI893460A0 FI893460A0 (en) 1989-07-17
FI893460A true FI893460A (en) 1990-01-20

Family

ID=6359009

Family Applications (1)

Application Number Title Priority Date Filing Date
FI893460A FI893460A (en) 1988-07-19 1989-07-17 ANVAENDNING AV SUBSTITUERADE 3,4-DIHYDRO -2H-BENSOPYRANER SOM LAEKEMEDEL MOT FUNKTIONSSTOERNINGAR VILKA TILLTAEPPER LUNGORNA, OCH / ELLER STOERNINGAR I DE AVLEDANDE URINROEREN.

Country Status (18)

Country Link
EP (2) EP0351720B1 (en)
JP (1) JPH0273015A (en)
KR (1) KR900001367A (en)
AT (1) ATE110270T1 (en)
AU (1) AU621388B2 (en)
CA (1) CA1336891C (en)
CZ (1) CZ417091A3 (en)
DE (2) DE3824446A1 (en)
DK (1) DK171782B1 (en)
ES (1) ES2061816T3 (en)
FI (1) FI893460A (en)
HU (1) HU210149B (en)
IE (1) IE63872B1 (en)
IL (1) IL91015A (en)
NZ (1) NZ229961A (en)
PH (1) PH26696A (en)
PT (1) PT91197B (en)
ZA (1) ZA895459B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW244350B (en) * 1991-12-14 1995-04-01 Hoechst Ag
TW316850B (en) * 1992-02-28 1997-10-01 Takeda Pharm Industry Co Ltd
HUT72741A (en) * 1992-12-19 1996-05-28 Alkaloida Vegyeszeti Gyar Method for producing benzopyrane derivatives and pharmaceutical compositions containing them
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
AU2273301A (en) 1999-12-23 2001-07-09 Robert E. Coifman Methods and formulations for the efficient delivery of water-insoluble drugs by nebulizer
KR100475147B1 (en) * 2002-09-09 2005-03-10 정의상 Remove noxious gas deodorant composite of alumina dust
AU2003274569B2 (en) 2002-11-12 2008-07-31 Warner-Lambert Company Llc Method of stimulating hair growth using benzopyrans

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3364734D1 (en) * 1982-10-19 1986-08-28 Beecham Group Plc Novel chromans and chromenes
GB8419515D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
GB8513369D0 (en) * 1985-05-28 1985-07-03 Beecham Group Plc Treatment
EP0277611B1 (en) * 1987-02-04 1993-06-16 Hoechst Aktiengesellschaft Alkyl-substituted n-benzopyranyl lactames, process for their preparation, their use and pharmaceutical preparations on the basis of these compounds
DE3703227A1 (en) * 1987-02-04 1988-08-18 Hoechst Ag SUBSTITUTED 3,4-DIHYDRO-2H-BENZOPYRANES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AND PHARMACEUTICAL PREPARATIONS BASED ON THESE COMPOUNDS

Also Published As

Publication number Publication date
CZ417091A3 (en) 1993-02-17
JPH0273015A (en) 1990-03-13
KR900001367A (en) 1990-02-27
IL91015A (en) 1994-11-28
HU210149B (en) 1995-02-28
NZ229961A (en) 1991-11-26
ATE110270T1 (en) 1994-09-15
ZA895459B (en) 1990-03-28
IE892323L (en) 1990-01-19
AU3818989A (en) 1990-01-25
EP0560399A1 (en) 1993-09-15
PH26696A (en) 1992-09-15
EP0351720A2 (en) 1990-01-24
AU621388B2 (en) 1992-03-12
DK355489A (en) 1990-01-20
EP0351720A3 (en) 1992-01-02
DK171782B1 (en) 1997-05-26
DK355489D0 (en) 1989-07-18
IE63872B1 (en) 1995-06-14
PT91197B (en) 1995-07-18
CA1336891C (en) 1995-09-05
DE3824446A1 (en) 1990-01-25
FI893460A0 (en) 1989-07-17
HUT55988A (en) 1991-07-29
PT91197A (en) 1990-02-08
DE58908228D1 (en) 1994-09-29
EP0351720B1 (en) 1994-08-24
ES2061816T3 (en) 1994-12-16

Similar Documents

Publication Publication Date Title
DE69129921D1 (en) Treatment of cataracts with 15-keto prostaglandin derivatives
BR1100662A (en) Pharmacologically acceptable compounds; use of a compound; and process for the preparation of compounds
ES2190469T3 (en) ISOCUMARINE DERIVATIVES AND ITS USE IN PHARMACOS.
DE69002996D1 (en) Triphenylmethane derivatives.
HK1000801A1 (en) Compounds having antitumor and antibacterial properties
FI893460A0 (en) ANVAENDNING AV SUBSTITUERADE 3,4-DIHYDRO -2H-BENSOPYRANER SOM LAEKEMEDEL MOT FUNKTIONSSTOERNINGAR VILKA TILLTAEPPER LUNGORNA, OCH / ELLER STOERNINGAR I DE AVLEDANDE URINROEREN.
IE880294L (en) Substituted 3,4-dihydro-2h-benzopyrans, process for their¹preparation, their use and pharmaceutical products based on¹these compounds
NO173237C (en) CHEMILUMINIZING ACRIDINE DERIVATIVES
ATE162181T1 (en) PHENYLALKAN(EN) ACIDS WITH LEUKOTRIENE B4 ANTAGONISTIC EFFECT
IE880295L (en) Alkyl-substitued n-benzopyranyllactams
ES8604604A1 (en) 3, 3&#34;, 4&#34; -Tri-O-acylspiramycin I.
DE69416191D1 (en) Spiropyran derivatives with photochromic properties
ES2112867T3 (en) SALTS OF ACIL- (2&#39;-HIDROXIBIFENIL-2-IL) -PHOSPHINICS ACIDS, THEIR PRODUCTION AND THEIR USE.
TR26593A (en) PROCEDURE FOR THE PRODUCTION OF HYDROPHIL STATUS TRIGLISERIDS.
ES517995A0 (en) A PROCEDURE FOR THE PREPARATION OF A HYDROXYBENCILAMINOBENZENE COMPOUND, PROVIDED WITH ANTI-INFLAMMATORY PROPERTIES.
DE69023045D1 (en) Carboxamide derivatives.
FI97883B (en) Process for the preparation of glycerol derivatives useful as a drug
ATE138914T1 (en) INDENO-D-PYRIMIDONE COMPOUNDS FOR USE IN MEDICINE
DK0631777T3 (en) Use of beta-naphtoquinone derivatives to inhibit platelet aggregation
ATE17570T1 (en) NEW 1,1,2-TRIPHENYL-BUT-1-EN DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS.
JPS5283773A (en) Novel indene derivative
IT1044236B (en) 2,2-Disubstd benzodioxoles - having antiinflammatory, analgesic, antitussive, CNS antiarrhythmic, and hypotensive properties
IT7928095A0 (en) COLORED PHOTOPOLYMER LAMP FOR FLASHES OF LIGHT WHICH HAS THE CASING COATED WITH AN ULTRAVIOLET WHICH IS POLYMERISABLE BY LIGHT.
JPS53124262A (en) Methylenomycin a derivatives and their preparation
JPS5325542A (en) 2-omega,omega-bis(alkylthio)-or omega,omega-(alkylenedithio)-alkyl)-3-methyl-2-cyclopenten-1-ones and their preparation

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT